[go: up one dir, main page]

MX9401623A - Derivados de taxano en c9 y composiciones farmaceuticas que los contienen. - Google Patents

Derivados de taxano en c9 y composiciones farmaceuticas que los contienen.

Info

Publication number
MX9401623A
MX9401623A MX9401623A MX9401623A MX9401623A MX 9401623 A MX9401623 A MX 9401623A MX 9401623 A MX9401623 A MX 9401623A MX 9401623 A MX9401623 A MX 9401623A MX 9401623 A MX9401623 A MX 9401623A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
compositions containing
taxane derivatives
taxane
derivatives
Prior art date
Application number
MX9401623A
Other languages
English (en)
Other versions
MXPA94001623A (es
Inventor
Robert A Holton
Ki-Byung Chai
Yukio Suzuki
Original Assignee
Univ Florida State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/026,978 external-priority patent/US5990325A/en
Application filed by Univ Florida State filed Critical Univ Florida State
Publication of MX9401623A publication Critical patent/MX9401623A/es
Publication of MXPA94001623A publication Critical patent/MXPA94001623A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describen derivados de taxano, que tienen sustituyentes alternativos en C9.
MXPA/A/1994/001623A 1993-03-05 1994-03-03 Derivados de taxano en c9 y composicionesfarmaceuticas que los contienen MXPA94001623A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/026,978 US5990325A (en) 1993-03-05 1993-03-05 Process for the preparation of 9-desoxotaxol, 9-desoxobaccatin III and analogs thereof
US08026978 1993-03-05
US3485293A 1993-03-22 1993-03-22
US034,852 1993-03-22
US9508793A 1993-07-20 1993-07-20
US095,087 1993-07-20

Publications (2)

Publication Number Publication Date
MX9401623A true MX9401623A (es) 1997-09-30
MXPA94001623A MXPA94001623A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
EP0688212B1 (en) 2002-06-12
AU6252594A (en) 1994-09-26
DE69430797D1 (de) 2002-07-18
ES2179070T3 (es) 2003-01-16
JP3892480B2 (ja) 2007-03-14
AU686137B2 (en) 1998-02-05
JPH08507309A (ja) 1996-08-06
PT688212E (pt) 2002-11-29
DE69430797T2 (de) 2003-02-27
WO1994020088A1 (en) 1994-09-15
IL108836A (en) 2005-11-20
IL108836A0 (en) 1994-06-24
EP1148055A1 (en) 2001-10-24
DK0688212T3 (da) 2002-10-07
ATE218858T1 (de) 2002-06-15
EP0688212A4 (en) 1996-03-20
EP0688212A1 (en) 1995-12-27

Similar Documents

Publication Publication Date Title
PL304649A1 (en) Novel derivatives of taxane and pharmaceutical agents
ZA94342B (en) C2 Taxane derivatives and pharmaceutical compositions containing them
GEP20002331B (en) Alkylated Raphamicine Derivatives
GEP20074251B (en) N-oxycarbonyl substituted 5'- deoxy-5-fluorocytidines
HUT74464A (en) 1n-alkyl-n-arylpyrimidinamines and derivatives thereof, and pharmaceutical compositions containing them
IL105715A0 (en) 7beta substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions containing them
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
MY124487A (en) Dolastatin derivatives, their preparation and use
HRP930239A2 (en) Anti-inflamatory 4-aminophenol derivatives
IL105717A0 (en) 7beta substituted-4-aza-5alpha-cholestan-3-ones and pharmaceutical compositions containing them
CA2160961A1 (fr) Nouveaux composes amides tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1108717A3 (en) C7 taxane derivatives and pharmaceutical compositions containing them
ZA941469B (en) C9 taxane derivatives and pharmaceutical compositions containing them
AU5339594A (en) Novel taxane derivatives, their preparation and pharmaceutical compositions containing them
CA2152771A1 (en) 7-o-ethers of taxane derivatives
IL110460A0 (en) Bis-naphthalimides and pharmaceutical compositions containing them
IL107555A0 (en) Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
IL108316A0 (en) C-10 taxana derivatives and pharmaceutical compositions containing them
IL108836A (en) C9 taxane derivatives and pharmaceutical compositions containing them
AU4075893A (en) Novel taxane derivatives, their preparation and compositions containing same
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
AU5994696A (en) Modified alpha-d-glcp-(1-2)-alpha-d-glcp-(1-3)-alpha-d-glcp- analogues
EP1108716A3 (en) C7 taxane derivatives and pharmaceutical compositions containing them
ZA926829B (en) Novel substituted taxanes and pharmaceutical compositions containing them.
AU666859C (en) Novel compositions based on taxane class derivatives

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees